DaVita Inc. Q2 2024 10-Q Filing

Ticker: DVA · Form: 10-Q · Filed: 2024-08-06T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, financials, debt

TL;DR

DaVita's Q2 10-Q is in: financials look stable, debt obligations are clear. Hold or sell?

AI Summary

DaVita Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial figures and debt obligations are presented, with specific dates and amounts indicating the company's financial standing and future commitments.

Why It Matters

This filing provides investors and analysts with a detailed look into DaVita's financial health and operational performance during the second quarter of 2024, impacting investment decisions.

Risk Assessment

Risk Level: medium — The filing contains detailed financial information, including debt, which can be complex and subject to market fluctuations.

Key Numbers

Key Players & Entities

FAQ

What was DaVita Inc.'s total revenue for the second quarter of 2024?

The filing does not explicitly state the total revenue for Q2 2024 in the provided snippet. Further review of the full 10-Q document is required.

What are the details of DaVita's debt obligations maturing in 2025 and 2026?

The filing indicates debt obligations with maturity dates of 12/31/2025 and 12/31/2026, with principal amounts of $1,000,000 and $500,000 respectively, and interest rates of 3.75% and 4.50%.

What is the interest rate on the debt maturing in 2027?

The debt maturing on 12/31/2027 has an interest rate of 4.00% and a principal amount of $750,000.

What is the fiscal year end for DaVita Inc.?

DaVita Inc.'s fiscal year ends on December 31st.

When was DaVita Inc. formerly known as DaVita Healthcare Partners Inc.?

DaVita Inc. was formerly known as DaVita Healthcare Partners Inc. on November 7, 2012.

From the Filing

0000927066-24-000128.txt : 20240806 0000927066-24-000128.hdr.sgml : 20240806 20240806170337 ACCESSION NUMBER: 0000927066-24-000128 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 79 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240806 DATE AS OF CHANGE: 20240806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 241180323 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 10-Q 1 dva-20240630.htm 10-Q dva-20240630 false 2024 Q2 0000927066 12/31 0.001 5,000 — 0.001 450,000 85,081 88,824 not Base + 1.75% Base + 1.75% Base + 1.75% 1,000,000 3.75 6/30/2024 12/31/2025 1,000,000 6/30/2024 12/31/2025 1,000,000 2024-06-30 12/31/2025 500,000 2024-06-30 12/31/2026 250,000 4.50 2024-12-31 12/31/2025 750,000 4.00 2024-12-31 12/31/2026 1,000,000 2025-12-31 12/31/2027 1,533,635 five years xbrli:shares iso4217:USD iso4217:USD xbrli:shares dva:segment xbrli:pure dva:Clinic 0000927066 2024-01-01 2024-06-30 0000927066 2024-08-02 0000927066 2024-04-01 2024-06-30 0000927066 2023-04-01 2023-06-30 0000927066 2023-01-01 2023-06-30 0000927066 2024-06-30 0000927066 2023-12-31 0000927066 2022-12-31 0000927066 2023-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-03-31 0000927066 us-gaap:CommonStockMember 2024-03-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000927066 us-gaap:RetainedEarningsMember 2024-03-31 0000927066 us-gaap:TreasuryStockCommonMember 2024-03-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000927066 us-gaap:ParentMember 2024-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2024-03-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-04-01 2024-06-30 0000927066 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000927066 us-gaap:ParentMember 2024-04-01 2024-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000927066 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000927066 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-06-30 0000927066 us-gaap:CommonStockMember 2024-06-30 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000927066 us-gaap:RetainedEarningsMember 2024-06-30 0000927066 us-gaap:TreasuryStockCommonMember 2024-06-30 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000927066 us-gaap:ParentMember 2024-06-30 0000927066 us-gaap:NoncontrollingInterestMember 2024-06-30 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2023-12-31 0000927066 us-gaap:CommonStockMember 2023-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000927066 us-gaap:RetainedEarningsMember 2023-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2023-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000927066 us-gaap:ParentMember 2023-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2023-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-01-01 2024-06-30 0000927066 us-gaap:RetainedEarningsMember 2

View on Read The Filing